Logo

Blockbuster Drugs...So Last Century?

Apr 03, 2007

Is the blockbuster model dead? Turna Ray, who writes GT’s sister publication Pharmacogenomics Reporter, posited that this might be the case for big pharma, which hopes to one day sell therapies more aligned with personalized treatment. There seems to be growing consensus: Chris Anderson, editor of Wired and author of the 2006 book, The Long Tail, blogged a few days ago about a New England Journal of Medicine article that ponders the potential demise of the one-size-fits-all blockbuster.

Breaking News
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.